The Food and Drug Administration Friday warned physicians and patients who use medical devices to monitor levels of the blood thinner warfarin that certain test strips used with the devices may provide inaccurate results and should not be relied on to adjust the drug dosage. The CoaguChek XS PT Test Strips were manufactured by Roche and distributed by Terrific Care/Medex Supply. They include catalog numbers for test strips that were excluded from a recent Roche recall because they were not labeled or authorized for sale in the U.S. However, Terrific Care/Medex Supply purchased the Roche test strips from an unknown source and imported and sold them in the U.S., FDA said. “Monitoring warfarin dosing is a critical part of using the drug properly to prevent and treat blood clots,” said FDA Commissioner Scott Gottlieb, M.D. “Using faulty strips can lead to errors in medication dosage that could cause serious harm or death in some patients. That’s why it’s so concerning that this distributor continued to sell these test strips in the U.S. even though domestic sales had been stopped due to safety concerns.”

Related News Articles

Headline
The Food and Drug Administration May 23 announced that Medline Industries, a firm marketing and distributing Chinese-manufactured plastic syringes within the U…
Blog
The inability of many patients to obtain needed drug therapies due to either high prices or shortages has negatively affected patient outcomes.1 Nearly 30% of…
Headline
The Food and Drug Administration yesterday announced an import alert for plastic syringes manufactured by two China-based manufacturers, in addition to…
Headline
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…
Headline
ASHP tracked a record 323 active drug shortages during the first quarter of 2024, surpassing the previous record of 320 shortages in 2014.“Some of the most…
Headline
The Department of Health and Human Services April 2 released a white paper proposing policy solutions for Congress and others to prevent drug shortages and…